Consent and assent in paediatric research in low-income settings

Phaik Yeong Cheah1, Michael Parker

  • 1Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok 10400, Thailand. phaikyeong@tropmedres.ac.

BMC Medical Ethics
|March 7, 2014
PubMed

Insights

Pediatric assent guidelines are confusing, especially in low-income countries. This paper proposes a context-specific model where competent children can consent for themselves based on local complexity standards.

Area of Science:

  • Bioethics
  • Pediatric Research
  • Global Health

Background:

  • Parental consent and child assent are recommended for pediatric research participation.
  • Current assent concepts present significant challenges for researchers and ethics committees.
  • Existing guidelines lack clarity and universal applicability, particularly in low-income settings.

Purpose of the Study:

  • To address the international debate on pediatric consent and assent.
  • To propose a fit-for-purpose assent model for low-income settings.
  • To advocate for context-specific approaches in pediatric research ethics.

Main Methods:

  • Review of the international debate on pediatric consent and assent.
  • Proposal of a context-specific assent model for low-income settings.
  • Exploration of practical challenges and counterarguments for implementation.

Main Results:

  • Competent children, judged by local standards, should be able to provide their own consent for research.
  • Assent should involve children to a degree compatible with their maturity and cultural norms.
  • Parental consent and child assent are necessary for children lacking decision-making competence.

Conclusions:

  • Current pediatric assent guidelines are confusing and require urgent clarification.
  • A context-specific approach is essential for assessing consent and assent in low-income settings.
  • Developing an evidence base for effective assent/consent practices in diverse settings is crucial.
Abstract

Related Concept Videos

Ethics in Research01:56

Ethics in Research

Today, scientists agree that good research is ethical in nature and is guided by a basic respect for human dignity and safety. However, this has not always been the case. Modern researchers must demonstrate that the research they perform is ethically sound.
23.7K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
408
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
967
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
248
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
554
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
410